Michael Eberlein1, Solbert Permutt2, Mayy F Chahla3, Servet Bolukbas4, Steven D Nathan5, Oksana A Shlobin5, James H Shelhamer6, Robert M Reed7, David B Pearse2, Jonathan B Orens2, Roy G Brower2. 1. Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD. Electronic address: michael-eberlein@uiowa.edu. 2. Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD. 3. Division of Hospital Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD. 4. Department of Thoracic Surgery, Horst-Schmidt-Klinik, Wiesbaden, Germany. 5. Advanced Lung Disease Program, Inova Fairfax Hospital, Falls Church, VA. 6. Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD. 7. Division of Pulmonary and Critical Care Medicine, School of Medicine, University of Maryland, Baltimore, MD.
Abstract
BACKGROUND: Size mismatch between donor lungs and a recipient thorax could affect the major determinants of maximal expiratory airflow: airway resistance, propensity of airways to collapse, and lung elastic recoil. METHODS: A retrospective review of 159 adults who received bilateral lung transplants was performed. The predicted total lung capacity (pTLC) for donors and recipients was calculated based on sex and height. Size matching was represented using the following formula: pTLC ratio = donor pTLC / recipient pTLC. Patients were grouped according to those with a pTLC ratio > 1.0 (oversized) or those with a pTLC ratio ≤ 1.0 (undersized). Allograft function was analyzed in relation to the pTLC ratio and to recipient and donor predicted function. RESULTS: The 96 patients in the oversized cohort had a mean pTLC ratio of 1.16 ± 0.13 vs 0.89 ± 0.09 in the 63 patients of the undersized group. At 1 to 6 months posttransplant, the patients in the oversized cohort had higher FEV(1)/FVC ratios (0.895 ± 0.13 vs 0.821 ± 0.13, P < .01) and lower time constant estimates of lung emptying (0.38 ± 0.2 vs 0.64 ± 0.4, P < .01) than patients in the undersized cohort. Although the FVCs expressed as % predicted for the recipient were not different between cohorts, the FVCs expressed as % predicted for the donor organ were lower in the oversized cohort compared with the undersized cohort (at 1-6 months, 52.4% ± 17.1% vs 65.3% ± 18.3%, P < .001). Kaplan-Meier estimates for the occurrence of bronchiolitis obliterans syndrome (BOS) showed that patients in the oversized cohort had a lower probability of BOS (P < .001). CONCLUSIONS: A pTLC ratio > 1.0, suggestive of an oversized allograft, is associated with higher expiratory airflow capacity and a less frequent occurrence of BOS.
BACKGROUND: Size mismatch between donor lungs and a recipient thorax could affect the major determinants of maximal expiratory airflow: airway resistance, propensity of airways to collapse, and lung elastic recoil. METHODS: A retrospective review of 159 adults who received bilateral lung transplants was performed. The predicted total lung capacity (pTLC) for donors and recipients was calculated based on sex and height. Size matching was represented using the following formula: pTLC ratio = donor pTLC / recipient pTLC. Patients were grouped according to those with a pTLC ratio > 1.0 (oversized) or those with a pTLC ratio ≤ 1.0 (undersized). Allograft function was analyzed in relation to the pTLC ratio and to recipient and donor predicted function. RESULTS: The 96 patients in the oversized cohort had a mean pTLC ratio of 1.16 ± 0.13 vs 0.89 ± 0.09 in the 63 patients of the undersized group. At 1 to 6 months posttransplant, the patients in the oversized cohort had higher FEV(1)/FVC ratios (0.895 ± 0.13 vs 0.821 ± 0.13, P < .01) and lower time constant estimates of lung emptying (0.38 ± 0.2 vs 0.64 ± 0.4, P < .01) than patients in the undersized cohort. Although the FVCs expressed as % predicted for the recipient were not different between cohorts, the FVCs expressed as % predicted for the donor organ were lower in the oversized cohort compared with the undersized cohort (at 1-6 months, 52.4% ± 17.1% vs 65.3% ± 18.3%, P < .001). Kaplan-Meier estimates for the occurrence of bronchiolitis obliterans syndrome (BOS) showed that patients in the oversized cohort had a lower probability of BOS (P < .001). CONCLUSIONS: A pTLC ratio > 1.0, suggestive of an oversized allograft, is associated with higher expiratory airflow capacity and a less frequent occurrence of BOS.
Authors: David P Mason; Lillian H Batizy; Jeffrey Wu; Edward R Nowicki; Sudish C Murthy; Ann M McNeill; Marie M Budev; Atul C Mehta; Gösta B Pettersson; Eugene H Blackstone Journal: J Thorac Cardiovasc Surg Date: 2009-05 Impact factor: 5.209
Authors: G Massard; M Badier; C Guillot; M Reynaud; P Thomas; R Giudicelli; M Noirclerc Journal: J Thorac Cardiovasc Surg Date: 1993-01 Impact factor: 5.209
Authors: Hisham Taher; Christian Bauer; Eric Abston; David W Kaczka; Surya P Bhatt; Joseph Zabner; Roy G Brower; Reinhard R Beichel; Michael Eberlein Journal: J Appl Physiol (1985) Date: 2018-01-04
Authors: Jason M Gauthier; Andrew J Bierhals; Jingxia Liu; Keki R Balsara; Christine Frederiksen; Emily Gremminger; Ramsey R Hachem; Chad A Witt; Elbert P Trulock; Derek E Byers; Roger D Yusen; Patrick R Aguilar; Gary Marklin; Ruben G Nava; Benjamin D Kozower; Michael K Pasque; Bryan F Meyers; G Alexander Patterson; Daniel Kreisel; Varun Puri Journal: J Thorac Cardiovasc Surg Date: 2018-11-24 Impact factor: 5.209
Authors: Michael Eberlein; Robert M Reed; Servet Bolukbas; Joshua M Diamond; Keith M Wille; Jonathan B Orens; Roy G Brower; Jason D Christie Journal: J Heart Lung Transplant Date: 2014-09-28 Impact factor: 10.247
Authors: Daniel C Chambers; Wida S Cherikh; Michael O Harhay; Don Hayes; Eileen Hsich; Kiran K Khush; Bruno Meiser; Luciano Potena; Joseph W Rossano; Alice E Toll; Tajinder P Singh; Aparna Sadavarte; Andreas Zuckermann; Josef Stehlik Journal: J Heart Lung Transplant Date: 2019-08-08 Impact factor: 10.247
Authors: Don Hayes; Wida S Cherikh; Daniel C Chambers; Michael O Harhay; Kiran K Khush; Rebecca R Lehman; Bruno Meiser; Joseph W Rossano; Eileen Hsich; Luciano Potena; Aparna Sadavarte; Tajinder P Singh; Andreas Zuckermann; Josef Stehlik Journal: J Heart Lung Transplant Date: 2019-08-08 Impact factor: 10.247